| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 639498 | Cyclopentanone, 2-[(dimethylamino)methyl]-5-(2-methyl- propylidene)-, hydrochloride | 0.0286383688883671 | -0.04182424 |
| NSC 639521 | Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-2-(phenylmethyl)-, hydrochloride | 0.0286383688883671 | 0.010634223 |
| NSC 639539 | Null | 0.0286383688883671 | 0.032249564 |
| NSC 658853 | Null | 0.0286383688883671 | 0.14529588 |
| NSC 123461 | Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) | 0.0339770934764509 | -0.015318899 |
| NSC 123463 | Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) | 0.0339770934764509 | -0.057901515 |
| NSC 150862 | BLEOMYCIN FRACTION BLM-HPE | 0.0339770934764509 | -0.24544556 |
| NSC 318807 | 1H-Azepine-1-carbothioic acid, hexahydro-, [1-(2- pyridinyl)ethylidene]hydrazide | 0.0339770934764509 | 0.23488361 |
| NSC 32937 | Benzenamine, 4-(9-chloro-10-ethyl-9,10-dihydro-9-acridinyl)-N,N-dimethyl-, dihydrochloride | 0.0339770934764509 | -0.019649088 |
| NSC 58575 | Pyrimidine, 2,4,5-trichloro-6-isopropyl- | 0.0339770934764509 | 0.11114317 |